Eyal Levit
Advanced Dermatology Laser and Cosmetic Surgery, USA
Title: Treatment of basal cell skin cancer in 2016: Tips and techniques
Biography
Biography: Eyal Levit
Abstract
Recent advances in the treatment of Basal Cell Skin Cancer (BCC) have targeted the PATCH gene mutation found in up to 80% of BCCs. The reported cure rate of these biological therapies is about 40%. The difficulty of these treatments is preventing the recurrence of the tumor once the biological therapy is discontinued. Current and new treatment options for skin cancer with their potential risks and benefits will be presented as well as a novel treatment modality utilizing the combination therapies of Imiquimod cream and Vismodegib to improve the cure rate to about 90%. A successfully cured case of a large BCC using Vismodigib and Imiquimod will be reviewed suggesting a promising path for non-surgical solution of BCC in selected cases.